C127H123BrN30O6S2 — CID 161266362
N-[3-(2-amino-4-pyridinyl)-5-(morpholin-4-ylmethyl)phenyl]-6-ethynylquinazolin-2-amine;[2-(2-anilino-7-piperidin-4-yloxyquinazolin-6-yl)-1,3-thiazol-4-yl]methanol;6-bromo-N-[3-(morpholin-4-ylmethyl)-5-pyrimidin-5-ylphenyl]quinazolin-2-amine;6-ethynyl-N-[3-[(4-methylpiperazin-1-yl)methyl]-5-(1-methylpyrazol-4-yl)phenyl]quinazolin-2-amine;N-[3-(5-methoxy-3-pyridinyl)phenyl]-7-(1-methylpiperidin-4-yl)oxy-6-(1,3-thiazol-2-yl)quinazolin-2-amine (PubChem CID 161266362) has the molecular formula C127H123BrN30O6S2 and a molecular weight of 2309.62 g/mol. Its IUPAC name is N-[3-(2-amino-4-pyridinyl)-5-(morpholin-4-ylmethyl)phenyl]-6-ethynylquinazolin-2-amine;[2-(2-anilino-7-piperidin-4-yloxyquinazolin-6-yl)-1,3-thiazol-4-yl]methanol;6-bromo-N-[3-(morpholin-4-ylmethyl)-5-pyrimidin-5-ylphenyl]quinazolin-2-amine;6-ethynyl-N-[3-[(4-methylpiperazin-1-yl)methyl]-5-(1-methylpyrazol-4-yl)phenyl]quinazolin-2-amine;N-[3-(5-methoxy-3-pyridinyl)phenyl]-7-(1-methylpiperidin-4-yl)oxy-6-(1,3-thiazol-2-yl)quinazolin-2-amine.
| Compound Name | N-[3-(2-amino-4-pyridinyl)-5-(morpholin-4-ylmethyl)phenyl]-6-ethynylquinazolin-2-amine;[2-(2-anilino-7-piperidin-4-yloxyquinazolin-6-yl)-1,3-thiazol-4-yl]methanol;6-bromo-N-[3-(morpholin-4-ylmethyl)-5-pyrimidin-5-ylphenyl]quinazolin-2-amine;6-ethynyl-N-[3-[(4-methylpiperazin-1-yl)methyl]-5-(1-methylpyrazol-4-yl)phenyl]quinazolin-2-amine;N-[3-(5-methoxy-3-pyridinyl)phenyl]-7-(1-methylpiperidin-4-yl)oxy-6-(1,3-thiazol-2-yl)quinazolin-2-amine |
|---|---|
| PubChem CID | 161266362 |
| Molecular Formula | C127H123BrN30O6S2 |
| Molecular Weight | 2309.62 g/mol |
| Exact Mass | 2306.89 |
| IUPAC Name | N-[3-(2-amino-4-pyridinyl)-5-(morpholin-4-ylmethyl)phenyl]-6-ethynylquinazolin-2-amine;[2-(2-anilino-7-piperidin-4-yloxyquinazolin-6-yl)-1,3-thiazol-4-yl]methanol;6-bromo-N-[3-(morpholin-4-ylmethyl)-5-pyrimidin-5-ylphenyl]quinazolin-2-amine;6-ethynyl-N-[3-[(4-methylpiperazin-1-yl)methyl]-5-(1-methylpyrazol-4-yl)phenyl]quinazolin-2-amine;N-[3-(5-methoxy-3-pyridinyl)phenyl]-7-(1-methylpiperidin-4-yl)oxy-6-(1,3-thiazol-2-yl)quinazolin-2-amine |
| SMILES | Brc1ccc2nc(Nc3cc(CN4CCOCC4)cc(-c4cncnc4)c3)ncc2c1.C#Cc1ccc2nc(Nc3cc(CN4CCN(C)CC4)cc(-c4cnn(C)c4)c3)ncc2c1.C#Cc1ccc2nc(Nc3cc(CN4CCOCC4)cc(-c4ccnc(N)c4)c3)ncc2c1.COc1cncc(-c2cccc(Nc3ncc4cc(-c5nccs5)c(OC5CCN(C)CC5)cc4n3)c2)c1.OCc1csc(-c2cc3cnc(Nc4ccccc4)nc3cc2OC2CCNCC2)n1 |
| InChI | InChI=1S/C29H28N6O2S.C26H27N7.C26H24N6O.C23H21BrN6O.C23H23N5O2S/c1-35-9-6-23(7-10-35)37-27-15-26-21(14-25(27)28-31-8-11-38-28)17-32-29(34-26)33-22-5-3-4-19(12-22)20-13-24(36-2)18-30-16-20;1-4-19-5-6-25-22(11-19)15-27-26(30-25)29-24-13-20(17-33-9-7-31(2)8-10-33)12-21(14-24)23-16-28-32(3)18-23;1-2-18-3-4-24-22(11-18)16-29-26(31-24)30-23-13-19(17-32-7-9-33-10-8-32)12-21(14-23)20-5-6-28-25(27)15-20;24-20-1-2-22-18(9-20)13-27-23(29-22)28-21-8-16(14-30-3-5-31-6-4-30)7-17(10-21)19-11-25-15-26-12-19;29-13-17-14-31-22(26-17)19-10-15-12-25-23(27-16-4-2-1-3-5-16)28-20(15)11-21(19)30-18-6-8-24-9-7-18/h3-5,8,11-18,23H,6-7,9-10H2,1-2H3,(H,32,33,34);1,5-6,11-16,18H,7-10,17H2,2-3H3,(H,27,29,30);1,3-6,11-16H,7-10,17H2,(H2,27,28)(H,29,30,31);1-2,7-13,15H,3-6,14H2,(H,27,28,29);1-5,10-12,14,18,24,29H,6-9,13H2,(H,25,27,28) |
| InChIKey | VDFWSYRUWAKJML-UHFFFAOYSA-N |
| XLogP | 21.92 |
| TPSA | 404.84 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 166 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2309.62 |
| LogP ≤ 5 | 21.92 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 38 |
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|